PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34934426-5	2022	In the present study, the use of a novel non-peptidic small molecule integrin alpha4 antagonist, AVA4746, as a potential new approach to combat drug-resistant B-ALL was explored.	UNII-7M2IM94F1S	97-104	integrin subunit alpha 4	Homo sapiens	69-84